{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T18:20:40Z","timestamp":1780078840522,"version":"3.54.0"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2020,2,25]],"date-time":"2020-02-25T00:00:00Z","timestamp":1582588800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,2,25]],"date-time":"2020-02-25T00:00:00Z","timestamp":1582588800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Mol Immunol"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1038\/s41423-020-0379-x","type":"journal-article","created":{"date-parts":[[2020,2,25]],"date-time":"2020-02-25T05:02:32Z","timestamp":1582606952000},"page":"1783-1797","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Hyperactive PI3K\u03b4 predisposes naive T cells to activation via aerobic glycolysis programs"],"prefix":"10.1038","volume":"18","author":[{"given":"Yanjun","family":"Jia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuyun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenyan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuemei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhirui","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minxuan","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjing","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lina","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenxia","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,2,25]]},"reference":[{"key":"379_CR1","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/j.immuni.2008.11.002","volume":"29","author":"CD Surh","year":"2008","unstructured":"Surh, C. D. & Sprent, J. Homeostasis of naive and memory T cells. Immunity 29, 848\u2013862 (2008).","journal-title":"Immunity"},{"key":"379_CR2","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1038\/nri2657","volume":"9","author":"K Takada","year":"2009","unstructured":"Takada, K. & Jameson, S. C. Naive T cell homeostasis: from awareness of space to a sense of place. Nat. Rev. Immunol. 9, 823\u2013832 (2009).","journal-title":"Nat. Rev. Immunol."},{"key":"379_CR3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fped.2016.00119","volume":"4","author":"SL Silva","year":"2016","unstructured":"Silva, S. L. & Sousa, A. E. Establishment and maintenance of the human na\u00efve CD4+ T-cell compartment. Front Pediatr. 4, 1\u201310 (2016).","journal-title":"Front Pediatr."},{"key":"379_CR4","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1126\/science.1243292","volume":"342","author":"I Angulo","year":"2013","unstructured":"Angulo, I. et al. Phosphoinositide 3-kinase \u03b4 gene mutation predisposes to respiratory infection and airway damage. Science 342, 866\u2013871 (2013).","journal-title":"Science"},{"key":"379_CR5","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/ni.2771","volume":"15","author":"CL Lucas","year":"2014","unstructured":"Lucas, C. L. et al. Dominant-activating germline mutations in the gene encoding the PI(3)K catalytic subunit p110\u03b4 result in T cell senescence and human immunodeficiency. Nat. Immunol. 15, 88\u201397 (2014).","journal-title":"Nat. Immunol."},{"key":"379_CR6","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/cei.12706","volume":"183","author":"M Elgizouli","year":"2016","unstructured":"Elgizouli, M. et al. Activating PI3K\u03b4 mutations in a cohort of 669 patients with primary immunodeficiency. Clin. Exp. Immunol. 183, 221\u2013229 (2016).","journal-title":"Clin. Exp. Immunol."},{"key":"379_CR7","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.jaci.2016.06.021","volume":"139","author":"TI Coulter","year":"2017","unstructured":"Coulter, T. I. et al. Clinical spectrum and features of activated phosphoinositide 3-kinase \u03b4 syndrome: a large patient cohort study. J. Allergy Clin. Immunol. 139, 597\u2013606.e4 (2017).","journal-title":"J. Allergy Clin. Immunol."},{"key":"379_CR8","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1016\/j.jaci.2019.03.017","volume":"143","author":"CJ Nunes-Santos","year":"2019","unstructured":"Nunes-Santos, C. J., Uzel, G. & Rosenzweig, S. D. PI3K pathway defects leading to immunodeficiency and immune dysregulation. J. Allergy Clin. Immunol. 143, 1676\u20131687 (2019).","journal-title":"J. Allergy Clin. Immunol."},{"key":"379_CR9","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.jaci.2019.01.033","volume":"144","author":"J Bier","year":"2019","unstructured":"Bier, J. et al. Activating mutations in PIK3CD disrupt the differentiation and function of human and murine CD4+ T cells. J. Allergy Clin. Immunol. 144, 236\u2013253 (2019).","journal-title":"J. Allergy Clin. Immunol."},{"key":"379_CR10","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.jaci.2018.04.030","volume":"143","author":"ESJ Edwards","year":"2019","unstructured":"Edwards, E. S. J. et al. Activating PIK3CD mutations impair human cytotoxic lymphocyte differentiation and function and EBV immunity. J. Allergy Clin. Immunol. 143, 276\u2013291.e6 (2019).","journal-title":"J. Allergy Clin. Immunol."},{"key":"379_CR11","doi-asserted-by":"crossref","first-page":"4330","DOI":"10.1073\/pnas.94.9.4330","volume":"94","author":"B Vanhaesebroeck","year":"1997","unstructured":"Vanhaesebroeck, B. et al. p110delta, a novel phosphoinositide 3-kinase in leukocytes. Proc. Natl Acad. Sci. USA 94, 4330\u20134335 (1997).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"379_CR12","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1146\/annurev-immunol-032712-095946","volume":"31","author":"K Okkenhaug","year":"2013","unstructured":"Okkenhaug, K. Signaling by the phosphoinositide 3-kinase family in immune cells. Annu Rev. Immunol. 31, 675\u2013704 (2013).","journal-title":"Annu Rev. Immunol."},{"key":"379_CR13","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1038\/nri.2016.93","volume":"16","author":"CL Lucas","year":"2016","unstructured":"Lucas, C. L., Chandra, A., Nejentsev, S., Condliffe, A. M. & Okkenhaug, K. PI3K\u03b4 and primary immunodeficiencies. Nat. Rev. Immunol. 16, 702\u2013714 (2016).","journal-title":"Nat. Rev. Immunol."},{"key":"379_CR14","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.4049\/jimmunol.175.5.2783","volume":"175","author":"LMC Webb","year":"2005","unstructured":"Webb, L. M. C., Vigorito, E., Wymann, M. P., Hirsch, E. & Turner, M. Cutting edge: T Cell development requires the combined activities of the p110\u03b3 and and p110\u03b4 catalytic catalytic isoforms of phosphatidylinositol 3-kinase. J. Immunol. 175, 2783\u20132787 (2005).","journal-title":"J. Immunol."},{"key":"379_CR15","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1084\/jem.20020805","volume":"196","author":"E Clayton","year":"2002","unstructured":"Clayton, E. et al. A crucial role for the p110delta subunit of phosphatidylinositol 3-kinase in B cell development and activation. J. Exp. Med 196, 753\u2013763 (2002).","journal-title":"J. Exp. Med"},{"key":"379_CR16","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1126\/science.1073560","volume":"297","author":"K Okkenhaug","year":"2002","unstructured":"Okkenhaug, K. Impaired B and T Cell antigen receptor signaling in p110delta PI3-kinase mutant mice. Science 297, 1031\u20131034 (2002).","journal-title":"Science"},{"key":"379_CR17","doi-asserted-by":"crossref","first-page":"8580","DOI":"10.1128\/MCB.22.24.8580-8591.2002","volume":"22","author":"S-T Jou","year":"2002","unstructured":"Jou, S.-T. et al. Essential, nonredundant role for the phosphoinositide 3-kinase p110delta in signaling by the B-cell receptor complex. Mol. Cell Biol. 22, 8580\u20138591 (2002).","journal-title":"Mol. Cell Biol."},{"key":"379_CR18","doi-asserted-by":"crossref","first-page":"5122","DOI":"10.4049\/jimmunol.177.8.5122","volume":"177","author":"K Okkenhaug","year":"2006","unstructured":"Okkenhaug, K. et al. The p110delta isoform of phosphoinositide 3-kinase controls clonal expansion and differentiation of Th cells. J. Immunol. 177, 5122\u20135128 (2006).","journal-title":"J. Immunol."},{"key":"379_CR19","doi-asserted-by":"crossref","first-page":"4042","DOI":"10.4049\/jimmunol.1001730","volume":"185","author":"J Rolf","year":"2010","unstructured":"Rolf, J. et al. Phosphoinositide 3-kinase activity in T cells regulates the magnitude of the germinal center reaction. J. Immunol. 185, 4042\u20134052 (2010).","journal-title":"J. Immunol."},{"key":"379_CR20","doi-asserted-by":"crossref","first-page":"3206","DOI":"10.4049\/jimmunol.1501227","volume":"195","author":"VQ Pearce","year":"2015","unstructured":"Pearce, V. Q., Bouabe, H., MacQueen, A. R., Carbonaro, V. & Okkenhaug, K. PI3K\u03b4 regulates the magnitude of CD8+T cell responses after challenge with listeria monocytogenes. J. Immunol. 195, 3206\u20133217 (2015).","journal-title":"J. Immunol."},{"key":"379_CR21","doi-asserted-by":"crossref","first-page":"3098","DOI":"10.4049\/jimmunol.0903177","volume":"184","author":"D Liu","year":"2010","unstructured":"Liu, D. & Uzonna, J. E. The p110delta Isoform of phosphatidylinositol 3-kinase controls the quality of secondary anti-leishmania immunity by regulating expansion and effector function of memory T cell subsets. J. Immunol. 184, 3098\u20133105 (2010).","journal-title":"J. Immunol."},{"key":"379_CR22","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.4049\/jimmunol.1501890","volume":"196","author":"DT Gracias","year":"2016","unstructured":"Gracias, D. T. et al. Phosphoinositide 3-Kinases p110\u03b4 isoform regulates CD8+ T cell responses during acute viral and intracellular bacterial infections. J. Immunol. 196, 1186\u20131198 (2016).","journal-title":"J. Immunol."},{"key":"379_CR23","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.4049\/jimmunol.0901099","volume":"183","author":"D Liu","year":"2009","unstructured":"Liu, D. et al. The p110 isoform of phosphatidylinositol 3-kinase controls susceptibility to leishmania major by regulating expansion and tissue homing of regulatory T cells. J. Immunol. 183, 1921\u20131933 (2009).","journal-title":"J. Immunol."},{"key":"379_CR24","first-page":"1154","volume":"118","author":"SJ Jarmin","year":"2008","unstructured":"Jarmin, S. J. et al. T cell receptor-induced phosphoinositide-3-kinase p110\u03b4 activity is required for T cell localization to antigenic tissue in mice. J. Clin. Invest 118, 1154\u20131164 (2008).","journal-title":"J. Clin. Invest"},{"key":"379_CR25","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/ni.1603","volume":"9","author":"LV Sinclair","year":"2008","unstructured":"Sinclair, L. V. et al. Phosphoinositide 3-kinase (PI3K) and nutrient sensing mTOR (mammalian target of rapamycin) pathways control T lymphocyte trafficking. Nat. Immunol. 9, 513\u2013521 (2008).","journal-title":"Nat. Immunol."},{"key":"379_CR26","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-017-00982-x","volume":"8","author":"M Uehara","year":"2017","unstructured":"Uehara, M. et al. Regulation of T cell alloimmunity by PI3K\u03b3 and PI3K\u03b4. Nat. Commun. 8, 951 (2017).","journal-title":"Nat. Commun."},{"key":"379_CR27","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1182\/blood-2009-07-232330","volume":"115","author":"DR Soond","year":"2010","unstructured":"Soond, D. R. et al. PI3K p110delta regulates T-cell cytokine production during primary and secondary immune responses in mice and humans. Blood 115, 2203\u20132213 (2010).","journal-title":"Blood"},{"key":"379_CR28","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1002\/eji.200636401","volume":"37","author":"BF Nashed","year":"2007","unstructured":"Nashed, B. F. et al. Role of the phosphoinositide 3-kinase p110\u03b4 in generation of type 2 cytokine responses and allergic airway inflammation. Eur. J. Immunol. 37, 416\u2013424 (2007).","journal-title":"Eur. J. Immunol."},{"key":"379_CR29","first-page":"673","volume":"33","author":"K Zhang","year":"2013","unstructured":"Zhang, K., Husami, A., Marsh, R. & Jordan, M. B. Identification of a phosphoinositide 3-kinase (PI-3K) P110delta(PIK3CD) deficient individual. J. Clin. Immunol. 33, 673\u2013674 (2013).","journal-title":"J. Clin. Immunol."},{"key":"379_CR30","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.jaci.2017.10.033","volume":"142","author":"N Sharfe","year":"2018","unstructured":"Sharfe, N. et al. Dual loss of p110\u03b4 PI3-kinase and SKAP (KNSTRN) expression leads to combined immunodeficiency and multisystem syndromic features. J. Allergy Clin. Immunol. 142, 618\u2013629 (2018).","journal-title":"J. Allergy Clin. Immunol."},{"key":"379_CR31","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1016\/j.jaci.2018.06.039","volume":"142","author":"G Sogkas","year":"2018","unstructured":"Sogkas, G. et al. Primary immunodeficiency disorder caused by phosphoinositide 3\u2013kinase \u03b4 deficiency. J. Allergy Clin. Immunol. 142, 1650\u20131653.e2 (2018).","journal-title":"J. Allergy Clin. Immunol."},{"key":"379_CR32","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.jaci.2018.10.005","volume":"143","author":"SB Cohen","year":"2019","unstructured":"Cohen, S. B. et al. Human primary immunodeficiency caused by expression of a kinase-dead p110\u03b4 mutant. J. Allergy Clin. Immunol. 143, 797\u2013799.e2 (2019).","journal-title":"J. Allergy Clin. Immunol."},{"key":"379_CR33","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1146\/annurev-immunol-032712-095956","volume":"31","author":"NJ MacIver","year":"2013","unstructured":"MacIver, N. J., Michalek, R. D. & Rathmell, J. C. Metabolic regulation of T lymphocytes. Annu Rev. Immunol. 31, 259\u2013283 (2013).","journal-title":"Annu Rev. Immunol."},{"key":"379_CR34","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1084\/jem.20151159","volume":"212","author":"MD Buck","year":"2015","unstructured":"Buck, M. D., O\u2019Sullivan, D. & Pearce, E. L. T cell metabolism drives immunity. J. Exp. Med 212, 1345\u20131360 (2015).","journal-title":"J. Exp. Med"},{"key":"379_CR35","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1146\/annurev-immunol-042617-053019","volume":"36","author":"RIK Geltink","year":"2018","unstructured":"Geltink, R. I. K., Kyle, R. L. & Pearce, E. L. Unraveling the complex interplay between T cell metabolism and function. Annu Rev. Immunol. 36, 461\u2013488 (2018).","journal-title":"Annu Rev. Immunol."},{"key":"379_CR36","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1038\/s41590-018-0182-3","volume":"19","author":"S Preite","year":"2018","unstructured":"Preite, S. et al. Hyperactivated PI3K\u03b4 promotes self and commensal reactivity at the expense of optimal humoral immunity. Nat. Immunol. 19, 986\u20131000 (2018).","journal-title":"Nat. Immunol."},{"key":"379_CR37","doi-asserted-by":"crossref","first-page":"10963","DOI":"10.1074\/jbc.274.16.10963","volume":"274","author":"L Bi","year":"1999","unstructured":"Bi, L., Okabe, I., Bernard, D. J., Wynshaw-Boris, A. & Nussbaum, R. L. Proliferative defect and embryonic lethality in mice homozygous for a deletion in the p110\u03b1 subunit of phosphoinositide 3-kinase. J. Biol. Chem. 274, 10963\u201310968 (1999).","journal-title":"J. Biol. Chem."},{"key":"379_CR38","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1126\/science.283.5400.393","volume":"283","author":"DA Fruman","year":"1999","unstructured":"Fruman, D. A. et al. Impaired B cell development and proliferation in absence of phosphoinositide 3-kinase p85\u03b1. Science 283, 393\u2013397 (1999).","journal-title":"Science"},{"key":"379_CR39","doi-asserted-by":"crossref","first-page":"6022","DOI":"10.1074\/jbc.275.8.6022","volume":"275","author":"JM Lu-Kuo","year":"2000","unstructured":"Lu-Kuo, J. M., Fruman, D. A., Joyal, D. M., Cantley, L. C. & Katz, H. R. Impaired Kit- but not Fc\u03b5RI-initiated mast cell activation in the absence of phosphoinositide 3-kinase p85\u03b1 gene products. J. Biol. Chem. 275, 6022\u20136029 (2000).","journal-title":"J. Biol. Chem."},{"key":"379_CR40","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1073\/pnas.1617244114","volume":"114","author":"GL Dornan","year":"2017","unstructured":"Dornan, G. L. et al. Conformational disruption of PI3K\u03b4 regulation by immunodeficiency mutations in PIK3CD and PIK3R1. Proc. Natl Acad. Sci. USA 114, 1982\u20131987 (2017).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"379_CR41","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-018-05674-8","volume":"9","author":"AK Stark","year":"2018","unstructured":"Stark, A. K. et al. PI3K\u03b4 hyper-activation promotes development of B cells that exacerbate Streptococcus pneumoniae infection in an antibody-independent manner. Nat. Commun. 9, 3174 (2018).","journal-title":"Nat. Commun."},{"key":"379_CR42","doi-asserted-by":"crossref","first-page":"e01020","DOI":"10.7554\/eLife.01020","volume":"2","author":"SR Daley","year":"2013","unstructured":"Daley, S. R. et al. Rasgrp1 mutation increases naive T-cell CD44 expression and drives mTOR-dependent accumulation of Helios+ T cells and autoantibodies. Elife 2, e01020 (2013).","journal-title":"Elife"},{"key":"379_CR43","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1084\/jem.20180617","volume":"215","author":"MN Wray-Dutra","year":"2018","unstructured":"Wray-Dutra, M. N. et al. Activated PIK3CD drives innate B cell expansion yet limits B cell\u2013intrinsic immune responses. J. Exp. Med. 215, 2485\u20132496 (2018).","journal-title":"J. Exp. Med."},{"key":"379_CR44","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1084\/jem.20180010","volume":"215","author":"DT Avery","year":"2018","unstructured":"Avery, D. T. et al. Germline-activating mutations in PIK3CD compromise B cell development and function. J. Exp. Med. 215, 2073\u20132095 (2018).","journal-title":"J. Exp. Med."},{"key":"379_CR45","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/imr.12790","volume":"291","author":"S Preite","year":"2019","unstructured":"Preite, S., Gomez-Rodriguez, J., Cannons, J. L. & Schwartzberg, P. L. T and B-cell signaling in activated PI3K delta syndrome: From immunodeficiency to autoimmunity. Immunol. Rev. 291, 154\u2013173 (2019).","journal-title":"Immunol. Rev."},{"key":"379_CR46","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.immuni.2009.02.003","volume":"30","author":"W Ouyang","year":"2009","unstructured":"Ouyang, W., Beckett, O., Flavell, R. A. & Li, M. O. An essential role of the forkhead-Box transcription factor Foxo1 in control of T cell homeostasis and tolerance. Immunity 30, 358\u2013371 (2009).","journal-title":"Immunity"},{"key":"379_CR47","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/ni.1689","volume":"10","author":"YM Kerdiles","year":"2009","unstructured":"Kerdiles, Y. M. et al. Foxo1 links homing and survival of naive T cells by regulating L- selectin, CCR7 and interleukin 7 receptor. Nat. Immunol. 10, 176\u2013184 (2009).","journal-title":"Nat. Immunol."},{"key":"379_CR48","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1038\/s41590-018-0157-4","volume":"19","author":"RH Newton","year":"2018","unstructured":"Newton, R. H. et al. Maintenance of CD4 T cell fitness through regulation of Foxo1. Nat. Immunol. 19, 838\u2013848 (2018).","journal-title":"Nat. Immunol."},{"key":"379_CR49","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.3389\/fimmu.2018.01758","volume":"9","author":"JL Cannons","year":"2018","unstructured":"Cannons, J. L., Preite, S., Kapnick, S. M., Uzel, G. & Schwartzberg, P. L. Genetic defects in phosphoinositide 3-kinase \u03b4 Influence CD8+ T Cell survival, differentiation, and function. Front Immunol. 9, 1758 (2018).","journal-title":"Front Immunol."},{"key":"379_CR50","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.3389\/fimmu.2017.02005","volume":"8","author":"J-M Carpier","year":"2018","unstructured":"Carpier, J.-M. & Lucas, C. L. Epstein\u2013Barr Virus susceptibility in activated PI3K\u03b4 syndrome (APDS) immunodeficiency. Front Immunol. 8, 2005 (2018).","journal-title":"Front Immunol."},{"key":"379_CR51","doi-asserted-by":"crossref","first-page":"446","DOI":"10.3389\/fimmu.2018.00446","volume":"9","author":"MWJ Wentink","year":"2018","unstructured":"Wentink, M. W. J. et al. Exhaustion of the CD8+ T cell compartment in patients with mutations in phosphoinositide 3-kinase delta. Front Immunol. 9, 446 (2018).","journal-title":"Front Immunol."},{"key":"379_CR52","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1016\/j.jaci.2019.03.017","volume":"143","author":"CJ Nunes-Santos","year":"2014","unstructured":"Nunes-Santos, C. J. et al. Dominant-activating germline mutations in the gene encoding the PI(3)K catalytic subunit p110\u03b4 result in T cell senescence and human immunodeficiency. J. Allergy Clin. Immunol. 143, 1676\u20131687 (2014).","journal-title":"J. Allergy Clin. Immunol."},{"key":"379_CR53","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.celrep.2014.03.006","volume":"7","author":"Y Imai","year":"2014","unstructured":"Imai, Y. et al. Crosstalk between the Rb Pathway and AKT signaling forms a quiescence-senescence switch. Cell Rep. 7, 194\u2013207 (2014).","journal-title":"Cell Rep."},{"key":"379_CR54","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1038\/onc.2011.394","volume":"31","author":"MV Astle","year":"2012","unstructured":"Astle, M. V. et al. AKT induces senescence in human cells via mTORC1 and p53 in the absence of DNA damage: implications for targeting mTOR during malignancy. Oncogene 31, 1949\u20131962 (2012).","journal-title":"Oncogene"},{"key":"379_CR55","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.immuni.2016.08.017","volume":"45","author":"H Zeng","year":"2016","unstructured":"Zeng, H. et al. mTORC1 and mTORC2 kinase signaling and glucose metabolism drive follicular helper T cell differentiation. Immunity 45, 540\u2013554 (2016).","journal-title":"Immunity"},{"key":"379_CR56","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.coi.2017.04.005","volume":"46","author":"H Zeng","year":"2017","unstructured":"Zeng, H. & Chi, H. mTOR signaling in the differentiation and function of regulatory and effector T cells. Curr. Opin. Immunol. 46, 103\u2013111 (2017).","journal-title":"Curr. Opin. Immunol."},{"key":"379_CR57","doi-asserted-by":"crossref","first-page":"543","DOI":"10.3389\/fimmu.2018.00543","volume":"9","author":"ME Maccari","year":"2018","unstructured":"Maccari, M. E. et al. Disease evolution and response to rapamycin in activated phosphoinositide 3-kinase \u03b4 syndrome: The european society for immunodeficiencies-activated phosphoinositide 3-kinase \u03b4 syndrome registry. Front Immunol. 9, 543 (2018).","journal-title":"Front Immunol."},{"key":"379_CR58","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.3389\/fimmu.2018.02043","volume":"9","author":"TI Coulter","year":"2018","unstructured":"Coulter, T. I. & Cant, A. J. The treatment of activated PI3K\u03b4 syndrome. Front Immunol. 9, 2043 (2018).","journal-title":"Front Immunol."},{"key":"379_CR59","doi-asserted-by":"crossref","first-page":"369","DOI":"10.3389\/fimmu.2018.00369","volume":"9","author":"D Michalovich","year":"2018","unstructured":"Michalovich, D. & Nejentsev, S. Activated PI3 kinase delta syndrome: from genetics to therapy. Front Immunol. 9, 369 (2018).","journal-title":"Front Immunol."},{"key":"379_CR60","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1182\/blood-2017-08-801191","volume":"130","author":"VK Rao","year":"2017","unstructured":"Rao, V. K. et al. Effective \u201cactivated PI3K\u03b4 syndrome\u201d\u2013targeted therapy with the PI3K\u03b4 inhibitor leniolisib. Blood 130, 2307\u20132316 (2017).","journal-title":"Blood"},{"key":"379_CR61","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/nature21406","volume":"542","author":"M Compagno","year":"2017","unstructured":"Compagno, M. et al. Phosphatidylinositol 3-kinase \u03b4 blockade increases genomic instability in B cells. Nature 542, 489\u2013493 (2017).","journal-title":"Nature"},{"key":"379_CR62","doi-asserted-by":"crossref","first-page":"274ra18","DOI":"10.1126\/scitranslmed.aaa0835","volume":"7","author":"Y Yin","year":"2015","unstructured":"Yin, Y. et al. Normalization of CD4+ T cell metabolism reverses lupus. Sci. Transl. Med 7, 274ra18 (2015).","journal-title":"Sci. Transl. Med"},{"key":"379_CR63","volume":"9","author":"SC Choi","year":"2018","unstructured":"Choi, S. C. et al. Inhibition of glucose metabolism selectively targets autoreactive follicular helper T cells. Nat. Commun. 9, 4369 (2018).","journal-title":"Nat. Commun."},{"key":"379_CR64","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/j.celrep.2015.09.036","volume":"13","author":"C-F Lee","year":"2015","unstructured":"Lee, C.-F. et al. Preventing allograft rejection by targeting immune metabolism. Cell Rep. 13, 760\u2013770 (2015).","journal-title":"Cell Rep."},{"key":"379_CR65","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.3389\/fimmu.2018.01973","volume":"9","author":"G Abboud","year":"2018","unstructured":"Abboud, G. et al. Inhibition of glycolysis reduces disease severity in an autoimmune model of rheumatoid arthritis. Front Immunol. 9, 1973 (2018).","journal-title":"Front Immunol."},{"key":"379_CR66","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1172\/JCI76012","volume":"125","author":"VA Gerriets","year":"2015","unstructured":"Gerriets, V. A. et al. Metabolic programming and PDHK1 control CD4+ T cell subsets and inflammation. J. Clin. Invest 125, 194\u2013207 (2015).","journal-title":"J. Clin. Invest"},{"key":"379_CR67","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/j.jaci.2018.04.022","volume":"142","author":"Y Ding","year":"2018","unstructured":"Ding, Y. et al. Reference values for peripheral blood lymphocyte subsets of healthy children in China. J. Allergy Clin. Immunol. 142, 970\u2013973.e8 (2018).","journal-title":"J. Allergy Clin. Immunol."}],"container-title":["Cellular &amp; Molecular Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41423-020-0379-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41423-020-0379-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41423-020-0379-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T17:23:19Z","timestamp":1684603399000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41423-020-0379-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,25]]},"references-count":67,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["379"],"URL":"https:\/\/doi.org\/10.1038\/s41423-020-0379-x","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.737445507.793578155","asserted-by":"object"}]},"ISSN":["1672-7681","2042-0226"],"issn-type":[{"value":"1672-7681","type":"print"},{"value":"2042-0226","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,25]]},"assertion":[{"value":"8 October 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}